GLP-1 Drug May Offer Short-Term Control of Obsessive Food Cravings
MONDAY, Nov. 24, 2025 (HealthDay News) — Researchers say a woman struggling with obesity who couldn’t resist eating fatty foods experienced declines in her cravings after taking tirzepatide, the GLP-1 weight-loss drug used in Mounjaro and Zepbound. Studies of the woman’s brain function suggest the drug quieted what the researchersContinue Reading










